(Q43542040)

24 November 2017

Analysis of the activated partial thromboplastin time test using mathematical modeling (English)

1 reference

24 November 2017

Kogan AE

1

1 reference

PubMed ID

11248291

24 November 2017

Kardakov DV

series ordinal

2

1 reference

PubMed ID

11248291

24 November 2017

Khanin MA

series ordinal

3

1 reference

24 November 2017

1 February 2001

1 reference

24 November 2017

1 reference

24 November 2017

101

1 reference

24 November 2017

4

1 reference

24 November 2017

299-310

1 reference

Initiation of blood coagulation at artificial surfaces

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

The interrelationship of coagulation of plasma and release of peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

Enzyme amplifier kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

A mathematical model of the kinetics of blood coagulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

An analysis of the contact phase of blood coagulation: effects of shear rate and surface are intertwined.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

Contact activation of the plasma coagulation cascade. I. Procoagulant surface chemistry and energy.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

Analysis of thrombin generation in plasma.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

Mathematical Model of Serine Protease Inhibition in the Tissue Factor Pathway to Thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

A mathematical model of the kinetics of platelets and plasma hemostasis system interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

Mathematical model for the blood coagulation prothrombin time test.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

Kinetics of activation and autoactivation of human factor XII.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

Factor XI activation in a revised model of blood coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

Intrinsic versus extrinsic coagulation. Kinetic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

Role of calcium ions and the heavy chain of factor XIa in the activation of human coagulation factor IX

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

Kinetics of the Factor XIa catalyzed activation of human blood coagulation Factor IX

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

Role of human factor VIII in factor X activation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

Kinetics of coagulation factor X activation by platelet-bound factor IXa

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

Activation of human factor V by factor Xa and thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

Mechanism of activation of bovine factor XI by factor XII and factor XIIa

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

Role of surface in surface-dependent activation of Hageman factor (blood coagulation Factor XII)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

Phospholipids accelerate factor IX activation by surface bound factor XIa

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

Comparison of the inhibition of thrombin by three plasma protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

Inhibition of prothrombinase complex by plasma proteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

Kinetics of the inhibition of factor Xa and the tissue factor-factor VIIa complex by the tissue factor pathway inhibitor in the presence and absence of heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

Effect of negatively charged activating compounds on inactivation of factor XIIa by Cl inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

A quantitative dot immunobinding assay for coagulation factor XII in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

Radioimmunoassays for protein C and factor X. Plasma antigen levels in abnormal hemostatic states

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

Human coagulation factor IX. Isolation and characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

Biochemistry and Physiology of Blood Coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

An integrated study of fibrinogen during blood coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

Fibrinogen blocks the autoactivation and thrombin-mediated activation of factor XI on dextran sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900405-9

7 January 2021

10.1016/S0049-3848(00)00405-9

Identifiers

DOI

1 reference

24 November 2017

1 reference

PubMed ID

11248291